RTTNews | Sep 22, 2021 10:03AM EDT

10:02 Wednesday, September 22, 2021 (RTTNews.com) - Cassava Sciences, Inc. (SAVA) shares are rising on Wednesday morning trade after the company reported positive results for its open-label study with Simufilam in Alzheimer's disease.

The company said the cognition scores improved 3.2 points on ADAS-Cog, baseline to month 12. The pivotal double-blind, placebo-controlled phase 3 clinical program is expected to be on track for the fourth quarter 2021.

Currently, shares are at $53.88, up 5 percent from the previous close of $52.86 on a volume of 8,156,299. The shares have traded in a range of $6.70-$146.16 for the 52-week period on average volume of 7,275,273.

Read the original article on RTTNews ( https://www.rttnews.com/3227494/cassava-shares-are-gaining-on-positive-results-for-simufilam-in-alzheimer-s-disease.aspx)

For comments and feedback: contact editorial@rttnews.com

Copyright(c) 2021 RTTNews.com All Rights Reserved